Maclean and Jansen Make the Case for Evidence Synthesis in Clinical Leader

In a new article for Clinical Leader, PHE’s Ross Maclean and Jeroen Jansen explain how evidence synthesis can reduce the guesswork of clinical trial design.

To read the complete article, please click here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.